Skip to main content
NewslettersWatchlist

Theseus Pharmaceuticals Inc(THRX-Q)
NASDAQ

Today's Change
Delayed Last Update

Theseus Pharmaceuticals Inc

314 MAIN STREET
CAMBRIDGE MA 02142 USA
P: 857-400-9491
http://www.theseusrx.com

Sectors & Indices

Sector
Industry
Employees

    Profile

    Theseus Pharmaceuticals Inc. is a biopharmaceutical company. It focused on improving the lives of cancer patients through the discovery, development and commercialization of transformative targeted therapies. The company's principal product candidate includes THE-630. Theseus Pharmaceuticals Inc. is based in CAMBRIDGE, Mass.

    Key Executives

    NameTitle
    Bradford D. DahmsCEO/CFO/Chief Accounting Officer/Director/President

    More from The Globe

    The close: Stocks higher as investors focus on Fed moves
    Traders work on the floor at the New York Stock Exchange (NYSE) in New York City, U.S., April 26.
    The close: Major North American indexes rise as megacap tech stocks rally
    A trader works on the floor at the New York Stock Exchange (NYSE) on April 25.
    Why this money manager is venturing back into emerging markets and adding more U.S. tech
    Illustration of Andrew Pyle for The Mover. Nov. 5, 2022. Illustration by Joel Kimmel
    How a Canadian pirate-clad pastor helped ignite Trump Media’s market frenzy
    Former President Donald Trump sits in Manhattan Criminal Court in New York, Thursday, April 25.
    Activist investor targets Dye & Durham’s ‘underperformance and strategic missteps’ in letter to shareholders
    Dye & Durham Ltd. says it has launched a strategic review of its non-core assets in an effort to reduce its debt. The logo for Dye & Durham Ltd. is shown in this undated handout photo. THE CANADIAN PRESS/HO
    The close: U.S. stocks fall as GDP report spreads rate-cut gloom; Alphabet surges 15% in post market
    Traders work on the floor of the New York Stock Exchange shortly after the opening bell, Wednesday, April 24.
    Fiera Capital’s largest shareholder looks to sell stake in company
    Jean-Guy Desjardins, global CEO and founder of Fire Capital posses for a portrait at Fiera Capital, in Montreal on Monday, January 8, 2024. Evan Buhler/The Globe and Mail�
    The close: S&P 500 higher as markets weigh rising bond yields and upbeat U.S. earnings; TSX lower as rails slide
    The Art Deco facade of the original Toronto Stock Exchange building is seen on Bay Street in Toronto in January of 2019.

    All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2024.

    Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

    Financial data provided by Zacks Investment Research.